These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 29991359)

  • 1. Hepatitis delta virus and hepatocellular carcinoma: an update.
    Romeo R; Petruzziello A; Pecheur EI; Facchetti F; Perbellini R; Galmozzi E; Khan NU; Di Capua L; Sabatino R; Botti G; Loquercio G
    Epidemiol Infect; 2018 Oct; 146(13):1612-1618. PubMed ID: 29991359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis D Virus and Hepatocellular Carcinoma.
    Farci P; Niro GA; Zamboni F; Diaz G
    Viruses; 2021 May; 13(5):. PubMed ID: 34064419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of the hepatitis Delta virus on the pathogenesis of hepatic cirrhosis and hepatocellular carcinoma. Recent advances].
    Romeo R
    Recenti Prog Med; 2010 Feb; 101(2):52-6. PubMed ID: 20433000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis D: A Review.
    Negro F; Lok AS
    JAMA; 2023 Dec; 330(24):2376-2387. PubMed ID: 37943548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma.
    Ji J; Sundquist K; Sundquist J
    J Natl Cancer Inst; 2012 May; 104(10):790-2. PubMed ID: 22423008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia.
    Mahale P; Aka P; Chen X; Pfeiffer RM; Liu P; Groover S; Mendy M; Njie R; Goedert JJ; Kirk GD; Glenn JS; O'Brien TR
    J Viral Hepat; 2019 Jun; 26(6):738-749. PubMed ID: 30661282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B/D-Related Hepatocellular Carcinoma. A Clinical Literature Review.
    Baskiran A; Atay A; Baskiran DY; Akbulut S
    J Gastrointest Cancer; 2021 Dec; 52(4):1192-1197. PubMed ID: 34611832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
    Ferrante ND; Lo Re V
    Curr HIV/AIDS Rep; 2020 Aug; 17(4):405-414. PubMed ID: 32607773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
    Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M
    PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
    Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
    J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
    Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
    BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN).
    Wranke A; Pinheiro Borzacov LM; Parana R; Lobato C; Hamid S; Ceausu E; Dalekos GN; Rizzetto M; Turcanu A; Niro GA; Lubna F; Abbas M; Ingiliz P; Buti M; Ferenci P; Vanwolleghem T; Hayden T; Dashdorj N; Motoc A; Cornberg M; Abbas Z; Yurdaydin C; Manns MP; Wedemeyer H; Hardtke S;
    Liver Int; 2018 May; 38(5):842-850. PubMed ID: 28963781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies.
    Kamal H; Fornes R; Simin J; Stål P; Duberg AS; Brusselaers N; Aleman S
    J Viral Hepat; 2021 Oct; 28(10):1431-1442. PubMed ID: 34291520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic.
    Sagnelli C; Pisaturo M; Curatolo C; Codella AV; Coppola N; Sagnelli E
    World J Gastroenterol; 2021 Nov; 27(42):7271-7284. PubMed ID: 34876788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between hepatocyte proliferation and hepatitis delta virus replication in neoplastic and non-neoplastic liver tissues.
    Negro F; Papotti M; Taraglio S; Rubbia-Brandt L; Giostra E; Pacchioni D; Rizzetto M; Hadengue A
    J Viral Hepat; 1997 Mar; 4(2):93-8. PubMed ID: 9097264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Signature and Mechanisms of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
    Diaz G; Engle RE; Tice A; Melis M; Montenegro S; Rodriguez-Canales J; Hanson J; Emmert-Buck MR; Bock KW; Moore IN; Zamboni F; Govindarajan S; Kleiner DE; Farci P
    Mol Cancer Res; 2018 Sep; 16(9):1406-1419. PubMed ID: 29858376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Delta hepatitis: Epidemiology, diagnostic, natural history and treatment].
    Loureiro D; Castelnau C; Bed CM; Asselah T
    Rev Med Interne; 2022 Mar; 43(3):160-169. PubMed ID: 34799189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis D virus dual infection increased the risk of hepatocellular carcinoma compared with hepatitis B virus mono infection: A meta-analysis.
    Chang TE; Su CW; Huang YS; Huang YH; Hou MC; Wu JC
    J Chin Med Assoc; 2022 Jan; 85(1):30-41. PubMed ID: 35006125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New epidemiology of hepatitis delta.
    Vlachogiannakos J; Papatheodoridis GV
    Liver Int; 2020 Feb; 40 Suppl 1():48-53. PubMed ID: 32077599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.